Bengaluru, India

Naveena Madhyastha

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naveena Madhyastha. Retrieved from https://idiyas.com/inventor/naveena-madhyastha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naveena Madhyastha: Innovator in Pyrimidine Compounds

Introduction

Naveena Madhyastha is a prominent inventor based in Bengaluru, India. She has made significant contributions to the field of medicinal chemistry, particularly through her work on pyrimidine compounds. Her innovative research has the potential to impact various therapeutic applications.

Latest Patents

Naveena holds a patent for "Pyrimidine compounds, compositions, and medicinal applications thereof." This patent encompasses a class of pyrimidine compounds, their stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, and hydrates. The disclosure also details a process for preparing these compounds, along with pharmaceutical compositions that contain them and their medicinal applications.

Career Highlights

Naveena is currently employed at Blueprint Medicines Corporation, where she continues to advance her research in medicinal applications. Her work is characterized by a commitment to developing innovative solutions in the pharmaceutical industry.

Collaborations

Some of her notable coworkers include Gurulingappa Hallur and Michael Rajesh Stephen, who contribute to her research endeavors and collaborative projects.

Conclusion

Naveena Madhyastha is a trailblazer in the field of pyrimidine compounds, with a focus on their medicinal applications. Her contributions are paving the way for future advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…